Contrast-enhanced mammography (CEM) has emerged as a viable alternative to contrast-
enhanced breast MRI, and it may increase access to vascular imaging while reducing …

In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI),
gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …

This paper summarizes information about breast MRI to be provided to women and referring
physicians. After listing contraindications, procedure details are described, stressing the …

Owing to their unique physical and chemical properties, magnetic iron oxide nanoparticles
have become a powerful platform in many diverse aspects of biomedicine, including …

The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA
organised a workshop in Milan on 20–21st October 2008 to evaluate the evidence currently …

Magnetic nanoparticles (MNPs) are highly appealing, particularly in the biomedical field.
Nanoparticles made of iron oxide have gained a lot of attention in the last decade due to …

The detection of lymph node metastasis affects the management of patients with primary
breast cancer significantly in terms of staging, treatment, and prognosis. The main goal for …

This paper presents an initial clinical evaluation of in vivo elastography for breast lesion
imaging using the concept of supersonic shear imaging. This technique is based on the …

The heavy global burden and mortality of breast cancer emphasize the importance of early
diagnosis and treatment. Imaging detection is one of the main tools used in clinical practice …

Machine‐learning techniques have led to remarkable advances in data extraction and
analysis of medical imaging. Applications of machine learning to breast MRI continue to …